Virtus KAR Health Sciences Fund is a registered fund series of Virtus Investment Trust (series S000007977). Net assets $89.8M as of 2026-03-31.
Showing 15 of 24 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co. | — | $11.9M | 1330.27% |
| Mckesson Corp. | — | $5.0M | 557.34% |
| Vertex Pharmaceuticals Incorporated | — | $4.6M | 509.23% |
| AbbVie Inc. | — | $4.6M | 508.84% |
| Merck & Co., Inc | — | $4.5M | 505.15% |
| Intuitive Surgical Inc. | — | $4.3M | 480.05% |
| West Pharmaceutical Services Incorporated | — | $4.0M | 440.10% |
| IDEXX Laboratories Inc. | — | $3.9M | 429.18% |
| Mettler-Toledo International Inc | — | $3.8M | 420.12% |
| The Cooper Companies, Inc. | — | $3.6M | 404.52% |
| Amgen Inc. | — | $3.6M | 399.01% |
| Regeneron Pharmaceuticals, Inc. | — | $3.4M | 382.53% |
| Thermo Fisher Scientific Inc | — | $3.4M | 381.79% |
| Danaher Corporation | — | $3.2M | 357.40% |
| Healthequity Inc | — | $3.1M | 342.41% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $89.8M |
| 2025-12-31 | $103.6M |
| 2025-09-30 | $96.5M |
| 2025-06-30 | $103.8M |
| 2025-03-31 | $111.8M |
| 2024-12-31 | $119.3M |
| 2024-09-30 | $141.4M |
| 2024-06-28 | $145.9M |